SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/58D7D75B7AC8B39A27E88939628285C25BCAA93445909E66D519B12D397D37A728A5AF381F3FCD000052C56D9B94688F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/58D7D75B7AC8B39A27E88939628285C25BCAA93445909E66D519B12D397D37A728A5AF381F3FCD000052C56D9B94688F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/58D7D75B7AC8B39A27E88939628285C25BCAA93445909E66D519B12D397D37A728A5AF381F3FCD000052C56D9B94688F
http://www.w3.org/2000/01/rdf-schema#comment
"early clinical trial data suggest that rhApo2L/TRAIL is generally safe and provide preliminary evidence for potential antitumor activity"
xsd:string
http://purl.uniprot.org/uniprot/#_8F8333E304F104180D2E4A31C4F8B35DBC867D80C30CB3F69F810F612589A0385B47AC3C919A4C042FE600AFEE9B79E5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/58D7D75B7AC8B39A27E88939628285C25BCAA93445909E66D519B12D397D37A728A5AF381F3FCD000052C56D9B94688F
http://purl.uniprot.org/uniprot/P50591
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/58D7D75B7AC8B39A27E88939628285C25BCAA93445909E66D519B12D397D37A728A5AF381F3FCD000052C56D9B94688F
http://purl.uniprot.org/uniprot/#_P50591-mappedCitation-18640940
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/58D7D75B7AC8B39A27E88939628285C25BCAA93445909E66D519B12D397D37A728A5AF381F3FCD000052C56D9B94688F